tiprankstipranks
Advertisement

SRPU ETF Price & Analysis

Compare

SRPU ETF Chart & Stats

5.88
--
Market closed
5.88
--

ETF Overview

Tradr 2X Long SRPT Daily ETF

The Tradr 2X Long SRPT Daily ETF (ticker: SRPU) is a specialized investment vehicle designed for those with an interest in the dynamic health care sector, specifically within the biotechnology niche. This ETF provides investors with the opportunity to achieve amplified returns by delivering 2x leveraged exposure to the daily performance of Sarepta Therapeutics, Inc. (SRPT), a leading company at the forefront of biotechnology innovation. By utilizing derivatives such as swap agreements, SRPU aims to magnify gains from the price movements of SRPT shares on a daily basis, net of fees and expenses. This makes it an appealing option for investors who are bullish on Sarepta's potential and are looking to capitalize on short-term price fluctuations. However, due to its leveraged nature, SRPU is best suited for sophisticated investors with a high risk tolerance and a keen understanding of the biotechnology sector's inherent volatility.

Tradr 2X Long SRPT Daily ETF (SRPU) Fund Flow Chart

Tradr 2X Long SRPT Daily ETF (SRPU) 1 year Net Flows: 6M

SRPU ETF FAQ

What was SRPU’s price range in the past 12 months?
SRPU lowest ETF price was 5.80 and its highest was 29.40 in the past 12 months.
    What is the AUM of SRPU?
    As of Jun 16, 2026 The AUM of SRPU is 2.75M.
      Is SRPU overvalued?
      Not enough analysts have published a price target to calculate whether the price is overvalued.
      Does SRPU pay dividends?
      SRPU does not currently pay dividends.
      How many shares outstanding does SRPU have?
      Currently, no data Available
      Which hedge fund is a major shareholder of SRPU?
      Currently, no hedge funds are holding shares in SRPU
      Popular ETFs
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis
      Advertisement